← Back to headlines
Kyntra Bio Targets Q4 2026 Interim Readout, Extends Cash Runway
Kyntra Bio aims for an interim readout in Q4 2026 and has successfully extended its cash runway into 2028, providing financial stability for its operations.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
